πŸ”₯πŸ” BizChicken πŸ”πŸ”₯

Companies Similar to Aligos Therapeutics, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Allakos Inc.

Allakos Inc. logo
Market Cap: Lowest
Employees: Low

lirentelimab (AK002)

Allakos Inc. is a clinical stage biopharmaceutical company that develops therapeutics targeting immunomodulatory receptors on immune cells for allergy, inflammatory, and proliferative diseases.

Tags: allergy, biopharmaceutical, immunomodulatory, inflammatory diseases, therapeutics

Symbol: ALLK

Recent Price: $1.19

Industry: Biotechnology

CEO: Dr. Robert Alexander Ph.D.

Sector: Healthcare

Employees: 131

Address: 975 Island Drive, Redwood City, CA 94065

Phone: 650 597 5002

Leadership

  • Robert Alexander, PhD, Chief Executive Officer
  • Robert Andreatta, CFA, Vice President, Controller
  • Neil Graham, MD, Chief Medical Officer
  • Steven James, Biopharma Executive
  • Amy Ladd, MD, Professor of Orthopaedic Surgery
  • Dolca Thomas, MD, Venture Partner
  • Paul Walker, CFA, Partner

Last updated: 2024-12-31

Alector, Inc.

Alector, Inc. logo
Market Cap: Medium
Employees: Low

AL001, AL101, AL002, AL003, AL044

Alector, Inc. is a clinical stage biopharmaceutical company focused on developing therapies for neurodegeneration diseases. The company has several products in various stages of clinical trials aimed at treating conditions such as Alzheimer's, Parkinson's, and frontotemporal dementia.

Tags: Alzheimer's, Parkinson's, biopharmaceutical, clinical trials, neurodegeneration, therapies

Symbol: ALEC

Recent Price: $1.72

Industry: Biotechnology

CEO: Dr. Arnon Rosenthal Ph.D.

Sector: Healthcare

Employees: 245

Address: 131 Oyster Point Boulevard, South San Francisco, CA 94080

Phone: 415 231 5660

Leadership

  • Arnon Rosenthal, Ph.D., Co-Founder, Chief Executive Officer, and Director
  • Sara Kenkare-Mitra, Ph.D., President and Head of Research and Development
  • Marc Grasso, M.D., Chief Financial Officer
  • Gary Romano, M.D., Ph.D., Chief Medical Officer
  • Danielle Pasqualone, Ph.D., J.D., General Counsel
  • Clare Hunt, M.B.A., Chief People Officer
  • Kristina Cutter, M.P.H., Chief Regulatory, Pharmacovigilance, and Quality Assurance Officer
  • Virginia DeJesus-Rueff, M.B.A., Chief of Staff and Head of Strategy
  • Norah Conway, Senior Vice President, Portfolio and Program Management
  • Neil Berkley, M.S., M.B.A., Chief Business Officer
  • Louis J. Lavigne Jr., M.B.A., Chairperson of the Board
  • Elizabeth Garofalo, M.D., Board Member
  • Paula Hammond, Ph.D., Board Member
  • Richard H. Scheller, Ph.D., Board Member
  • David Wehner, Board Member
  • Kristine Yaffe, M.D., Board Member
  • Errol De Souza, Ph.D., Board Member
  • Mark Altmeyer, M.B.A., Board Member

Last updated: 2024-12-31

Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

ELI-002

Elicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for cancer and other diseases, with its lead product ELI-002 targeting KRAS-driven cancers.

Tags: Biotechnology, Cancer Treatment, Clinical-stage, Immunotherapy, Vaccines

Symbol: ELTX

Recent Price: $5.00

Industry: Biotechnology

CEO: Mr. Robert T. Connelly

Sector: Healthcare

Employees: 32

Address: 451 D Street, Boston, MA 02210

Phone: 857-209-0050

Last updated: 2024-12-31

ImmunityBio, Inc.

ImmunityBio, Inc. logo
Market Cap: High
Employees: Medium

Therapies and Vaccines

Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.

Tags: biotechnology, cancer, cell therapy, immunotherapy, infectious diseases, vaccines

Symbol: IBRX

Recent Price: $2.68

Industry: Biotechnology

CEO: Mr. Richard Gerald Adcock

Sector: Healthcare

Employees: 622

Address: 3530 John Hopkins Court, San Diego, CA 92121

Phone: 858 633 0300

Last updated: 2024-12-31

Vera Therapeutics, Inc.

Vera Therapeutics, Inc. logo
Market Cap: High
Employees: Low

atacicept

Vera Therapeutics, Inc. is a clinical stage biotechnology company focusing on developing and commercializing treatments for serious immunological diseases, including atacicept for immunoglobulin A nephropathy and MAU868 for BK viremia infections.

Tags: MAU868, atacicept, biotechnology, clinical trial, immunological diseases

Symbol: VERA

Recent Price: $42.06

Industry: Biotechnology

CEO: Dr. Marshall W. Fordyce M.D.

Sector: Healthcare

Employees: 72

Address: 8000 Marina Boulevard, Brisbane, CA 94005

Phone: 650 770 0077

Last updated: 2024-12-31

Adicet Bio, Inc.

Adicet Bio, Inc. logo
Market Cap: Low
Employees: Low

ADI-001

Adicet Bio, Inc. is a biotechnology company focused on discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Their lead product ADI-001 is in Phase I clinical study for non-Hodgkin's lymphoma, with additional products in development for solid tumors.

Tags: allogeneic treatments, biotechnology, cancer therapy, gamma delta T cell, immunotherapy

Symbol: ACET

Recent Price: $0.90

Industry: Biotechnology

CEO: Mr. Chen Schor BA, CPA, M.B.A.

Sector: Healthcare

Employees: 143

Address: 200 Clarendon Street, Boston, MA 02116

Phone: 650 503 9095

Last updated: 2024-12-31

Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

UCART19

Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer.

Tags: CAR T cell, allogeneic T cell therapies, cancer treatment, clinical trials, immuno-oncology

Symbol: ALLO

Recent Price: $2.10

Industry: Biotechnology

CEO: Dr. David D. Chang M.D., Ph.D.

Sector: Healthcare

Employees: 232

Address: 210 East Grand Avenue, South San Francisco, CA 94080

Phone: 650 457 2700

Last updated: 2024-12-31

AlloVir, Inc.

AlloVir, Inc. logo
Market Cap: Low
Employees: Lowest

posoleucel

Allovir, Inc. is a clinical-stage cell therapy company focused on the development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat viral-associated diseases. It was founded in 2013 and is based in Waltham, Massachusetts.

Tags: VST therapies, biotechnology, cell therapy, clinical-stage, viral diseases

Symbol: ALVR

Recent Price: $0.45

Industry: Biotechnology

CEO: Dr. Diana M. Brainard M.D.

Sector: Healthcare

Employees: 8

Address: 1100 Winter Street, Waltham, MA 02451

Phone: 617 433 2605

Last updated: 2024-12-31

ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc. logo
Market Cap: Low
Employees: Low

ALX148

ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company developing therapies for cancer patients. Its lead product, ALX148, targets CD47 and is in trials for various cancers. The company also explores pre-clinical treatments like ALTA-002 to enhance immune response to cancer.

Tags: CD47, cancer therapy, clinical trials, collaboration, immuno-oncology, solid tumors

Symbol: ALXO

Recent Price: $1.66

Industry: Biotechnology

CEO: Mr. Jason W. Lettmann

Sector: Healthcare

Employees: 81

Address: 323 Allerton Avenue, South San Francisco, CA 94080

Phone: 650 466 7125

Last updated: 2024-12-31

Apogee Therapeutics, Inc.

Apogee Therapeutics, Inc. logo
Market Cap: High
Employees: Low

APG777, APG808, APG990, APG222

Apogee Therapeutics, Inc. is a biotechnology company developing biologics for the treatment of atopic dermatitis, COPD, and related inflammatory and immunology conditions. Founded in 2022 and based in Waltham, Massachusetts.

Tags: COPD, atopic dermatitis, biologics, biotechnology, clinical stage, immunology, inflammatory

Symbol: APGE

Recent Price: $44.64

Industry: Biotechnology

CEO: Dr. Michael Thomas Henderson M.D.

Sector: Healthcare

Employees: 91

Address: 221 Crescent Street, Waltham, MA 02453

Phone: 650-394-5230

Last updated: 2024-12-31

Assembly Biosciences, Inc.

Assembly Biosciences, Inc. logo
Market Cap: Low
Employees: Low

Vebicorvir

Assembly Biosciences, Inc. is a clinical-stage biotechnology company focused on discovering and developing therapeutic candidates for the treatment of hepatitis B virus (HBV) infection. Their lead product candidate, Vebicorvir, has completed Phase 2 clinical trials. The company is engaged in additional development and collaboration agreements to advance treatments for HBV.

Tags: Vebicorvir, biotechnology, clinical trials, hepatitis B, therapeutics

Symbol: ASMB

Recent Price: $16.03

Industry: Biotechnology

CEO: Mr. Jason A. Okazaki

Sector: Healthcare

Employees: 65

Address: 331 Oyster Point Boulevard, South San Francisco, CA 94080

Phone: 833 509 4583

Last updated: 2024-12-31

89bio, Inc.

89bio, Inc. logo
Market Cap: Medium
Employees: Low

pegozafermin

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for liver and cardio-metabolic diseases, primarily through its lead product candidate, pegozafermin, designed to treat nonalcoholic steatohepatitis and severe hypertriglyceridemia.

Tags: biopharmaceutical, cardio-metabolic, clinical-stage, hypertriglyceridemia, liver diseases, nonalcoholic steatohepatitis, pegozafermin

Symbol: ETNB

Recent Price: $7.87

Industry: Biotechnology

CEO: Mr. Rohan Palekar

Sector: Healthcare

Employees: 70

Address: 142 Sansome Street, San Francisco, CA 94104

Phone: 415 432 9270

Last updated: 2024-12-31

BioXcel Therapeutics, Inc.

BioXcel Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Low

IGALMI

Bio Xcel Therapeutics, Inc. is a biopharmaceutical company leveraging artificial intelligence for developing transformative medicines in neuroscience and immuno-oncology. It focuses on re-innovating existing drugs with machine learning to identify new therapeutic uses.

Tags: agitation treatment, artificial intelligence, biopharmaceutical, clinical trials, immuno-oncology, neuroscience

Symbol: BTAI

Recent Price: $0.37

Industry: Biotechnology

CEO: Dr. Vimal D. Mehta Ph.D.

Sector: Healthcare

Employees: 74

Address: 555 Long Wharf Drive, New Haven, CT 06511

Phone: 475 238 6837

Last updated: 2024-12-31

IGM Biosciences, Inc.

IGM Biosciences, Inc. logo
Market Cap: Medium
Employees: Low

IGM-2323

IGM Biosciences, Inc. is a biotechnology company focused on developing Immunoglobulin M (Ig M) antibodies for treating cancer, infectious diseases, and autoimmune and inflammatory diseases. Their lead product candidate, IGM-2323, is in Phase 2 clinical trials for B cell Non-Hodgkin's lymphoma.

Tags: antibodies, biotechnology, cancer, clinical trials, pharmaceutical

Symbol: IGMS

Recent Price: $6.05

Industry: Biotechnology

CEO: Ms. Mary Beth Harler M.D.

Sector: Healthcare

Employees: 204

Address: 325 East Middlefield Road, Mountain View, CA 94043

Phone: 650 965 7873

Last updated: 2024-12-31

LogicBio Therapeutics, Inc.

LogicBio Therapeutics, Inc. logo
Market Cap: Low
Employees: Medium

LB-001

Logic Bio Therapeutics, Inc. is a genetic medicine company focused on genome editing and gene therapy treatments using its Gene Ride and s AAVy platforms. Its lead product candidate, LB-001, is in clinical trials for methylmalonic acidemia.

Tags: Gene Ride, LB-001, gene therapy, genetic medicine, genome editing, methylmalonic acidemia, s AAVy

Symbol: LOGC

Recent Price: $7.08

Industry: Biotechnology

CEO: Mr. Rishi Bajaj

Sector: Healthcare

Employees: 452

Address: 65 Hayden Ave, 2Nd Floor, Lexington, MASSACHUSETTS 02421

Phone: 16172450399

Last updated: 2024-12-31

Regulus Therapeutics Inc.

Regulus Therapeutics Inc. logo
Market Cap: Low
Employees: Lowest

RG-012 and RGLS8429

Regulus Therapeutics Inc., based in San Diego, focuses on discovering and developing drugs targeting micro RNAs for treating various diseases.

Tags: biopharmaceutical, clinical stage, drug development, kidney disease, micro RNAs

Symbol: RGLS

Recent Price: $1.50

Industry: Biotechnology

CEO: Mr. Joseph P. Hagan M.B.A.

Sector: Healthcare

Employees: 30

Address: 4224 Campus Point Court, San Diego, CA 92121

Phone: 858 202 6300

Last updated: 2024-12-31

Alaunos Therapeutics, Inc.

Alaunos Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

Adoptive TCR Engineered T-cell Therapies

Alaunos Therapeutics is a clinical-stage company focused on developing cell therapies for cancer treatment, utilizing TCR engineered T-cell therapies in clinical trials for various cancers.

Tags: TCR Library, biotechnology, cancer treatment, cell therapy, clinical trials, oncology

Symbol: TCRT

Recent Price: $2.17

Industry: Biotechnology

CEO: Mr. Dale Curtis Hogue Jr.

Sector: Healthcare

Employees: 1

Address: 8030 El Rio Street, Houston, TX 77054

Phone: 346 355 4099

Last updated: 2024-12-31

Vir Biotechnology, Inc.

Vir Biotechnology, Inc. logo
Market Cap: Medium
Employees: Medium

Sotrovimab (VIR-7832), VIR-2218, VIR-3434, VIR-2482, VIR-1111

Vir Biotechnology, Inc. is a commercial-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases, including COVID-19, hepatitis B, influenza A, and HIV.

Tags: COVID-19, HIV, biotechnology, hepatitis B, immunology, infectious diseases, influenza, therapeutics

Symbol: VIR

Recent Price: $7.33

Industry: Biotechnology

CEO: Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.

Sector: Healthcare

Employees: 587

Address: 499 Illinois Street, San Francisco, CA 94158

Phone: 415 906 4324

Leadership

  • Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer and Director
  • Jeff Calcagno, M.D., Executive Vice President and Chief Business Officer
  • Vanina de Verneuil, J.D., Executive Vice President, General Counsel and Corporate Secretary
  • Mika Kakefuda Derynck, M.D., Executive Vice President, Therapeutic Area Head Oncology
  • Mark Eisner, M.D., M.P.H., Executive Vice President and Chief Medical Officer
  • Jenny Gumm, Ed.D., MBA, Executive Vice President, Chief Human Resources Officer
  • Aine Hanly, Ph.D., Executive Vice President and Chief Technology Officer
  • Jason O’Byrne, MBA, Executive Vice President and Chief Financial Officer
  • Jennifer Eileen Towne, Ph.D., Executive Vice President and Chief Scientific Officer
  • Arran Attridge, Senior Vice President Corporate Communications
  • Antonio Lanzavecchia, M.D., Senior Vice President and Senior Research Fellow
  • Amalio Telenti, M.D, Ph.D., Executive Vice President and Senior Research Fellow

Last updated: 2024-12-31

Aligos Therapeutics, Inc.

Aligos Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Low

ALG-010133

Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for viral and liver diseases, with a focus on chronic hepatitis B and non-alcoholic steatohepatitis.

Tags: NASH, biopharmaceutical, chronic hepatitis B, liver diseases, therapeutics

Symbol: ALGS

Recent Price: $40.47

Industry: Biotechnology

CEO: Dr. Lawrence M. Blatt MBA, Ph.D.

Sector: Healthcare

Employees: 68

Address: One Corporate Drive, South San Francisco, CA 94080

Phone: 800 466 6059

Last updated: 2024-12-31

Tango Therapeutics, Inc.

Tango Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

TNG908

Tango Therapeutics, Inc. is a biotechnology company focused on discovering and developing drugs for cancer treatment, with a lead program TNG908 targeting cancers with methylthioadenosine phosphorylase deletions. The company also works on therapies for BRCA1/2-mutant and STK11-mutant cancers and collaborates with Gilead Sciences, Inc.

Tags: BRCA1/2-mutant cancers, Gilead Sciences, STK11-mutant cancers, TNG908, biotechnology, cancer treatment, drug development, methylthioadenosine phosphorylase, protein arginine methyltransferase 5, strategic collaboration, synthetic lethal

Symbol: TNGX

Recent Price: $3.10

Industry: Biotechnology

CEO: Dr. Barbara L. Weber M.D.

Sector: Healthcare

Employees: 140

Address: 100 Binney Street, Cambridge, MA 02142

Phone: 857 320 4900

Last updated: 2024-12-31